DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES. (June 2017)